Korean J Obstet Gynecol.
2000 May;43(5):914-917.
A case of advanced ovarian cancer which was treated with topotecan after taxol-cisplatin treatment failed
Abstract
- Ovarian cancer has the highest mortality rate among gynecologic malignancies in developed countries. Most women present with advanced disease and require a combination of surgery and chemotherapy. One patient presented with recurrent ovarian cancer was initially treated with taxol and platinum-based compounds. Although response to these agents occurred, tumor progression was evident by elevated CA 125 levels and CT findings after a period of 4 months. This patient was then treated with topotecan and exhibited a response and stopped therapy. Topotecan exhibited activity in this patient with ovarian cancer resistent to both platinum and paclitaxel. We report a case of advanced ovarian cancer which was treated with topotecan after taxol-cisplatin treatment failed.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Study on Measure of Chemosensitivities to Topotecan, Cisplatin and Taxol Theraphy in Ovarian Cancer Cell Lines: Relationship with p53 and bcl-2 Expression and Apoptosis
- Effect of Topotecan in Combication with Other Antitumor Drugs in Vitro
- Mutation of DNA Mismatch Repair Genes and its Relation to Taxol and Topotecan Chemosensitivity in the Clones from the Cisplatin-Resistant Ovarian Cancer Cell Lines
- The role of topotecan as second-line chemotherapy in patients with recurrent epithelial ovarian cancer
- In Vitro Interaction of Taxol with Other Antitumor Drugs in the Established Choriocarcinoma Cell Lines
